Annual Shareholders Equity
$8.27 M
-$13.49 M-62.00%
31 December 2023
Summary:
Predictive Oncology annual stockholders equity is currently $8.27 million, with the most recent change of -$13.49 million (-62.00%) on 31 December 2023. During the last 3 years, it has risen by +$5.63 million (+213.01%). POAI annual shareholders equity is now -79.46% below its all-time high of $40.27 million, reached on 31 December 2021.POAI Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$1.97 M
-$2.13 M-51.95%
30 September 2024
Summary:
Predictive Oncology quarterly stockholders equity is currently $1.97 million, with the most recent change of -$2.13 million (-51.95%) on 30 September 2024. Over the past year, it has dropped by -$9.68 million (-83.12%). POAI quarterly shareholders equity is now -96.29% below its all-time high of $53.09 million, reached on 30 June 2021.POAI Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
POAI Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -62.0% | -83.1% |
| 3 y3 years | +213.0% | -95.9% |
| 5 y5 years | +10000.0% | -90.5% |
POAI Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -79.5% | +213.0% | -95.9% | at low |
| 5 y | 5 years | -79.5% | >+9999.0% | -96.3% | at low |
| alltime | all time | -79.5% | +249.9% | -96.3% | +132.0% |
Predictive Oncology Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.97 M(-52.0%) |
| June 2024 | - | $4.09 M(+1.0%) |
| Mar 2024 | - | $4.05 M(-51.0%) |
| Dec 2023 | $8.27 M(-62.0%) | $8.27 M(-29.0%) |
| Sept 2023 | - | $11.65 M(-20.8%) |
| June 2023 | - | $14.71 M(-20.7%) |
| Mar 2023 | - | $18.55 M(-14.8%) |
| Dec 2022 | $21.77 M(-45.9%) | $21.77 M(-26.4%) |
| Sept 2022 | - | $29.59 M(-11.8%) |
| June 2022 | - | $33.54 M(-9.8%) |
| Mar 2022 | - | $37.18 M(-7.7%) |
| Dec 2021 | $40.27 M(+1423.7%) | $40.27 M(-15.7%) |
| Sept 2021 | - | $47.78 M(-10.0%) |
| June 2021 | - | $53.09 M(+49.4%) |
| Mar 2021 | - | $35.55 M(+1245.0%) |
| Dec 2020 | $2.64 M(-76.5%) | $2.64 M(-78.4%) |
| Sept 2020 | - | $12.24 M(+4.7%) |
| June 2020 | - | $11.69 M(+12.9%) |
| Mar 2020 | - | $10.36 M(-7.8%) |
| Dec 2019 | $11.23 M(>+9900.0%) | $11.23 M(-45.8%) |
| Sept 2019 | - | $20.71 M(-7.1%) |
| June 2019 | - | $22.29 M(>+9900.0%) |
| Mar 2019 | - | $70.00 K(+30.8%) |
| Dec 2018 | $53.50 K(-98.0%) | $53.50 K(-98.2%) |
| Sept 2018 | - | $3.03 M(-10.0%) |
| June 2018 | - | $3.36 M(-35.5%) |
| Mar 2018 | - | $5.22 M(+93.8%) |
| Dec 2017 | $2.69 M(+191.4%) | $2.69 M(+18.0%) |
| Sept 2017 | - | $2.28 M(-28.7%) |
| June 2017 | - | $3.20 M(-19.7%) |
| Mar 2017 | - | $3.98 M(+331.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $923.70 K(-77.5%) | $923.70 K(+7932.2%) |
| Sept 2016 | - | $11.50 K(-98.5%) |
| June 2016 | - | $785.20 K(-69.0%) |
| Mar 2016 | - | $2.53 M(-38.4%) |
| Dec 2015 | $4.11 M(-174.6%) | $4.11 M(-29.3%) |
| Sept 2015 | - | $5.81 M(-194.6%) |
| June 2015 | - | -$6.14 M(+10.8%) |
| Mar 2015 | - | -$5.54 M(+0.5%) |
| Dec 2014 | -$5.52 M(+71.4%) | -$5.52 M(+43.8%) |
| Sept 2014 | - | -$3.83 M(+19.0%) |
| June 2014 | - | -$3.22 M(+94.6%) |
| Mar 2014 | - | -$1.66 M(-48.5%) |
| Dec 2013 | -$3.22 M(-2.6%) | -$3.22 M(+166.3%) |
| Sept 2013 | - | -$1.21 M(-65.4%) |
| June 2013 | - | -$3.49 M(+22.7%) |
| Mar 2013 | - | -$2.84 M(-13.9%) |
| Dec 2012 | -$3.30 M(+22.2%) | -$3.30 M(+48.2%) |
| Sept 2012 | - | -$2.23 M(-1.7%) |
| June 2012 | - | -$2.27 M(-23.2%) |
| Mar 2012 | - | -$2.95 M(+9.2%) |
| Dec 2011 | -$2.70 M(+23.5%) | -$2.70 M(+9.2%) |
| Sept 2011 | - | -$2.47 M(+1.5%) |
| June 2011 | - | -$2.44 M(+9.1%) |
| Mar 2011 | - | -$2.24 M(+2.1%) |
| Dec 2010 | -$2.19 M(-6.5%) | -$2.19 M(+6.8%) |
| Sept 2010 | - | -$2.05 M(+2.1%) |
| June 2010 | - | -$2.01 M(-19.3%) |
| Mar 2010 | - | -$2.49 M(+6.2%) |
| Dec 2009 | -$2.34 M(+656.9%) | -$2.34 M(+2.7%) |
| Sept 2009 | - | -$2.28 M(+637.0%) |
| Dec 2008 | -$309.40 K | -$309.40 K |
FAQ
- What is Predictive Oncology annual stockholders equity?
- What is the all time high annual shareholders equity for Predictive Oncology?
- What is Predictive Oncology annual shareholders equity year-on-year change?
- What is Predictive Oncology quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Predictive Oncology?
- What is Predictive Oncology quarterly shareholders equity year-on-year change?
What is Predictive Oncology annual stockholders equity?
The current annual shareholders equity of POAI is $8.27 M
What is the all time high annual shareholders equity for Predictive Oncology?
Predictive Oncology all-time high annual stockholders equity is $40.27 M
What is Predictive Oncology annual shareholders equity year-on-year change?
Over the past year, POAI annual stockholders equity has changed by -$13.49 M (-62.00%)
What is Predictive Oncology quarterly stockholders equity?
The current quarterly shareholders equity of POAI is $1.97 M
What is the all time high quarterly shareholders equity for Predictive Oncology?
Predictive Oncology all-time high quarterly stockholders equity is $53.09 M
What is Predictive Oncology quarterly shareholders equity year-on-year change?
Over the past year, POAI quarterly stockholders equity has changed by -$9.68 M (-83.12%)